Advertisement
Home Tags Anticoagulants

Tag: Anticoagulants

Clinical practice guidelines for anticoagulation therapy for cardiopulmonary bypass have been developed and were published in the February issue of the Annals of Thoracic Surgery.

Anticoagulation Guidance Issued for Cardiopulmonary Bypass

0
Recommendations for heparin dosing and monitoring, contraindications and alternatives, reversal
Prasugrel carries no increased ocular risk compared with clopidogrel

Ocular Safety Profile of Novel Oral Antithrombotics Explored

0
Prasugrel has no increased ocular risk versus clopidogrel; dabigatran, rivaroxaban may reduce risk
The addition of pharmacomechanical thrombolysis does not reduce the risk of post-thrombotic syndrome among patients with acute proximal deep vein thrombosis

Pharmacomechanical Thrombolysis No Benefit in DVT

0
Addition of pharmacomechanical catheter-directed thrombolysis resulted in higher risk of bleeding
The chemical stability of warfarin sodium tablets is not affected by repackaging into dose administration aids

Storage in Dose Administration Aids Doesn’t Affect Warfarin

0
Repackaging of warfarin sodium tablets into dose administration aids doesn't affect chemical stability
A decision pathway has been developed to guide management of acute bleeding in patients treated with oral anticoagulants; the decision pathway was published online Dec. 1 in the Journal of the American College of Cardiology.

ACC Guides Treatment of Bleeding With Oral Anticoagulation

0
Pathway supports clinician decision making during management of patients with bleeding complications
For patients with atrial fibrillation

NOACs Show Lower Risk of Adverse Renal Outcomes in A-Fib

0
Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes
Genotype-guided warfarin dosing is associated with reduced risk of adverse events compared with clinically-guided dosing among patients undergoing elective hip or knee arthroplasty

Genotype-Guided Warfarin Dosing Cuts Adverse Events

0
Risk of composite of major bleeding, INR ≥4, VTE, death down for hip, knee arthroplasty patients
For elderly patients treated with vitamin K antagonists for venous thromboembolism

CYP2C9 Variants Linked to Clinical Events in VTE

0
Risk of any clinical event, death, non-major bleeding up for seniors treated with vitamin K antagonists
Less than 45 percent of older adults with atrial fibrillation admitted to the hospital are prescribed an anticoagulant

Less Than Half of Seniors With A-Fib Receive Anticoagulants

0
Increase in overall anticoagulant use over time, mainly due to increase in new oral anticoagulants
Online training for nurses has been found to increase hospital patients' use of venous thromboembolism prophylaxis

Online Nursing Education Can Up Patient Use of VTE Prophylaxis

0
Online training aims to make sure those hospitalized get treatment to prevent venous thromboembolism